Skip to main content
Hit enter to search or ESC to close
Close Search
Global Health Impact GroupGlobal Health Impact GroupGlobal Health Impact GroupGlobal Health Impact GroupGlobal Health Impact GroupGlobal Health Impact Group
Menu
  • Home
  • About Us
  • Areas of Technical Expertise
    • AMR
    • COVID-19
    • Global Diseases
    • Health Systems Strengthening
    • HIV
    • Innovations & Diagnostics
    • Maternal & Child Health
    • Publications
  • Our Mission
  • Contact Us
    Category

    Innovations & Diagnostics

    Evaluation of Zika Singleplex and Multiplex diagnostics for clinical and surveillance use Global DiseasesInnovations & DiagnosticsTechnical Assistance

    Evaluation of Zika Singleplex and Multiplex diagnostics for clinical and surveillance use

    GHIG is currently working with the London School of Hygiene and Tropical Medicine (LSHTM) as…
    Point-of-Care Day in Latin America Health Systems StrengtheningInnovations & DiagnosticsWorkshops

    Point-of-Care Day in Latin America

    GHIG participated in the 2nd annual POC Day in Bogota to support the uptake of…
    Evaluation of Grants and Investments in New Diagnostics Advisory/ConsultancyInnovations & DiagnosticsMaternal & Child HealthTechnical Assistance

    Evaluation of Grants and Investments in New Diagnostics

    GHIG was asked to serve as an advisor collaborating with Cambridge Economic Policy Associates (CEPA)…
    An Investment Case for Lateral Flow Assays (LFAs) for Neglected Tropical Diseases (NTD) Global DiseasesInnovations & DiagnosticsTechnical Assistance

    An Investment Case for Lateral Flow Assays (LFAs) for Neglected Tropical Diseases (NTD)

    Ultrasensitive antigen tests are needed for early detection of numerous infectious diseases, and for surveillance…
    Industry Innovations in HIV Viral Load (VL) Advisory/ConsultancyHIVInnovations & Diagnostics

    Industry Innovations in HIV Viral Load (VL)

    GHIG has worked with numerous industry partners to bring about innovations in HIV viral load…
    Accelerating Market Entry and Quality of HIV Point-of-Care (POC) Diagnostics HIVInnovations & DiagnosticsProgram Planning & Implementation

    Accelerating Market Entry and Quality of HIV Point-of-Care (POC) Diagnostics

    The Global Health Impact Group (GHIG) provided technical assistance and direction to the 3-year project…

    Tags

    Advanced HIV Disease (AHD) (4) Africa (3) Africa CDC (3) Antimicrobial Resistance (AMR) (2) Antiretroviral (ARV) (1) Bio banking (3) CD4 (3) Conference (1) Connectivity (1) Cost (1) COVID-19 (6) Diagnostics (2) Drones (1) Early Infant Diagnosis (EID) (5) Evaluations (1) Global Diseases (1) Global Health (1) Global Health Continuing Professional Development (GHCPD) (1) Guidance (1) Health Systems (1) Hepatitis (2) HIV (7) Laboratory Medicine (1) Lateral Flow Assays (LFAs) (2) Massive open online course (MOOC) (1) Neglected Tropical Diseases (NTD) (3) Outbreaks (1) PAHO (1) Panels (1) POINT-OF-CARE (2) Point-of-Care (POC) (3) Policy (1) Quality (1) QUALITY ASSURANCE (QA) (3) Serology (4) Supply Chain (1) Syphilis (1) VIRAL LOAD (VL) (8) WHO (1) Zika (3)

    © 2026 Global Health Impact Group.

    • linkedin
    • youtube
    Close Menu
    • Home
    • About Us
    • Areas of Technical Expertise
      • AMR
      • COVID-19
      • Global Diseases
      • Health Systems Strengthening
      • HIV
      • Innovations & Diagnostics
      • Maternal & Child Health
      • Publications
    • Our Mission
    • Contact Us
    • twitter
    • facebook
    • instagram